Your browser doesn't support javascript.
loading
Rebound pain after interscalene brachial plexus block for shoulder surgery: a randomized clinical trial of the effect of different multimodal analgesia regimens.
Et, Tayfun; Basaran, Betul; Bilge, Aysegul; Yarimoglu, Rafet; Korkusuz, Muhammet; Tülüce, Ibrahim.
Afiliação
  • Et T; From the Department of Anesthesiology and Intensive Care Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
  • Basaran B; From the Department of Anesthesiology and Intensive Care Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
  • Bilge A; From the Department of Anesthesiology and Intensive Care Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
  • Yarimoglu R; From the Department of Anesthesiology and Intensive Care Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
  • Korkusuz M; From the Department of Anesthesiology and Intensive Care Medicine, Karamanoglu Mehmetbey University, Karaman, Turkey.
  • Tülüce I; From the Department of Orthopedics and Traumatology, Karaman Training and Research Hospital, Karaman, Turkey.
Ann Saudi Med ; 43(6): 339-347, 2023.
Article em En | MEDLINE | ID: mdl-38071444
ABSTRACT

BACKGROUND:

Rebound pain is characterized by sudden, significant acute postoperative pain occurring after the resolution of inter-scalene block (ISB); it affects the quality of recovery postoperatively. Dexamethasone increases ISB resolution time and decreases opioid consumption and the incidence of rebound pain.

OBJECTIVE:

Evaluate whether multimodal analgesia including intravenous dexamethasone administration with preoperative ISB reduces the incidence of rebound pain.

DESIGN:

Prospective, randomized, controlled trial.

SETTING:

Tertiary university hospital. SAMPLE SIZE 60 patients. PATIENTS AND

METHODS:

Patients who underwent shoulder surgery under general anesthesia were assigned randomly to two different multimodal analgesia protocols. Thirty patients received 5 mg IV dexamethasone with non-steroid, paracetamol, and ISB with 15 mL 0.5% bupivacaine, while the control patients received the same regimen and ISB with 15 mL 0.5% bupivacaine without dexamethasone. Postoperative opioids were given to any patient on demand. MAIN OUTCOMES

MEASURES:

Effect of IV dexamethasone on pain score and incidence of rebound pain after ISB resolution and postoperative opioid consumption at 0-48 hours, numerical pain rating scale (NPRS) scores, sleep scale scores, and quality of recovery-15 scores (QoR-15).

RESULTS:

The incidence of rebound pain was lower in the dexamethasone group than in the control group (73.3% and 30%, respectively, P=.001). NPRS scores after ISB resolution were lower in the dexamethasone group (5 ([4-7]), 8 ([5.75-8]), P<.001, respectively). Those who received IV dexamethasone had less sleep disturbances (P<.001) and higher QoR-15 on day 1 (P<.001) and day 7 (P=.020) postoperatively.

CONCLUSIONS:

IV dexamethasone added to the ISB block resulted in a lower incidence of rebound pain. In addition, better results were obtained in postoperative sleep quality and QoR-15.

LIMITATIONS:

Single-center study.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bloqueio do Plexo Braquial / Analgesia Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bloqueio do Plexo Braquial / Analgesia Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article